NTHI · Neonc Technologies Holdings, Inc.
$3.68
+0.02 (+0.55%)
At close · Sep 11
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern one year from the issuance date of this Form 10-Q. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company is actively taking steps to mitigate the substantial doubt about the Company's ability to continue as a going concern, including pursuing additional financing.”View the 10-Q filed Aug 10, 2026
Market Cap
$95.45M
Shares
25.94M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.68
Open$3.69
Day$3.45–3.72
52W close$3.21–12.09
Avg vol 30d251K
Short int471K · 1.8% float · 2.3d
Short vol73%
Last earningsAug 12, 2026
DataMar 2025–Sep 2026
Filing10-Q · Aug 10
Up next
Next earnings call
Nov 6, 2026
Est · unconfirmed
· in 8 wks
filed Aug 10, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$47.20M
Trailing 12 months
Revenue growth YoY
-51.8%
Year over year
Operating margin
-145,637.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.97M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+29.6%
Year over year · more shares
Price change (1Y)
-62.3%
Trailing year
Short interest
1.8%
Latest settlement · 2.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−43%
below
Price vs 50-day avg
−9%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
5%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+15%
trailing
6-month return
−50%
trailing
YTD return
−56%
this year
Relative strength
−68%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +2 funds added
Insider flow
Accumulating
Net +$318.4K over 90 days · 0% sells
Short interest
Falling
1.82% of float · ▼ -21.1% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — mid 1-yr range
Squeeze score
47
elevated · 0–100
Fundamentals
Revenue growth
−52%
Y/Y
EPS growth
−364%
Y/Y
Quant / Vol
risk profile
Volatility
112%
annualized · 1-yr
Max drawdown
−73%
past year
ATR
13.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−43%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +2 funds added
Insider flow
Accumulating
Net +$318.4K over 90 days · 0% sells
Short interest
Falling
1.82% of float · ▼ -21.1% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $3
Now $4 · 5%
Range high $12
vs 200-day avg -43%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NTHI
this stock
Neonc Technologies Holdings, Inc.
|
$95.45M | -55.5% | -51.8% | — | 1.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.64B | +13.7% | +46.2% | 30.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$80.46B | +1.2% | +20.8% | 19.4 | 2.5% |
|
ARGX
Argenx SE
|
$61.22B | +17.1% | — | — | 2.0% |
|
MRNA
Moderna, Inc.
|
$57.48B | +388.2% | +4.3% | — | 9.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NTHI | -23.2% | +14.6% | -49.7% | -25.5% | -55.5% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -22.0% | +16.4% | -67.5% | -25.2% | -67.6% |